These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3274440)

  • 21. Factors influencing cadaver kidney graft survival in two cyclosporine periods.
    Pappalettera M; Pizzi C; Cardillo M; Piccolo G; Aniasi A; Lecchi L; Poli F; Sirchia G
    Transplant Proc; 1994 Oct; 26(5):2533-4. PubMed ID: 7940779
    [No Abstract]   [Full Text] [Related]  

  • 22. Trial of cyclosporine vs OG37-325 in cadaveric renal transplantation: a preliminary report.
    Henry ML; Tesi RJ; Elkhammas EA; Ferguson RM
    Transplant Proc; 1993 Feb; 25(1 Pt 1):689-90. PubMed ID: 8438438
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclosporine A, hyperimmunized patients, and renal retransplantation.
    Hendriks GF; de Lange P; Persijn GG; van Rood JJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):733-4. PubMed ID: 3274857
    [No Abstract]   [Full Text] [Related]  

  • 24. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D; Bardideh A; Samadzadeh B; Razi A
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of HLA-DR and combined HLA-B and HLA-DR matching on early graft outcome under cyclosporine therapy.
    Vanrenterghem Y; Roels L; Waer M; Gruwez J; Dendievel J; Michielsen P
    Transplant Proc; 1987 Feb; 19(1 Pt 1):685-6. PubMed ID: 3274841
    [No Abstract]   [Full Text] [Related]  

  • 26. Transfusion, HLA, and cyclosporine in kidney transplantation.
    Tiwari JL
    Clin Transpl; 1987; ():459-65. PubMed ID: 3154446
    [No Abstract]   [Full Text] [Related]  

  • 27. Donor-specific transfusion for kidney transplantation in the cyclosporine era.
    Inoue S; Aikawa M; Dobashi Y; Kuzuhara K; Yanagisawa T; Ootubo O; Mimura N
    Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of chronic rejection by cyclosporine and prednisone.
    Arnold AN; Anaise D; Miller F; Waltzer WC; Rapaport FT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2122-3. PubMed ID: 3274479
    [No Abstract]   [Full Text] [Related]  

  • 29. Reduction of the center effect by HLA matching.
    Gjertson DW; Terasaki PI; Cecka JM; Takemoto S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):215-6. PubMed ID: 8438276
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of HLA matching, type of crossmatch, and immunosuppressive therapy on primary pediatric cadaver renal allograft survival.
    Kerman RH; Sullivan EK; Tejani A
    Transplant Proc; 1995 Feb; 27(1):656-7. PubMed ID: 7879133
    [No Abstract]   [Full Text] [Related]  

  • 31. Primary cadaveric renal transplantation using cyclosporine in patients over fifty years of age.
    Mandelbaum DM; Henry ML; Sommer BG; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1863-4. PubMed ID: 3274443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detrimental effect of ABO mismatching in renal transplantation.
    Stock P; Sutherland DE; Fryd DS; Ascher NL; Payne WD; Simmons RL; Najarian JS
    Transplant Proc; 1987 Feb; 19(1 Pt 1):711-2. PubMed ID: 3274850
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative study of two protocols for living-related renal transplantation: donor-specific transfusion versus cyclosporine.
    Mazzali M; Alves Filho G; Alves MA; de Faria JB
    Transplant Proc; 1995 Apr; 27(2):1832-3. PubMed ID: 7725525
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporine immunosuppression in cadaver kidney recipients with a remote positive crossmatch to the current donor.
    Belitsky P
    Transplant Proc; 1985 Aug; 17(4):1937-9. PubMed ID: 3895633
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of HLA matching, donor age, and cyclosporine on unrelated pediatric renal allograft survival.
    Groenwoud AF; Persijn GG; Hendriks GF; D'Amaro J; Cohen B
    Transplant Proc; 1987 Feb; 19(1 Pt 1):699-701. PubMed ID: 3274847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of HLA matching in 10,000 cyclosporine-treated cadaver kidney transplants.
    Opelz G
    Transplant Proc; 1987 Feb; 19(1 Pt 1):641-6. PubMed ID: 3547834
    [No Abstract]   [Full Text] [Related]  

  • 38. Factors on graft survival of living donor kidney transplantation in a single center.
    Jin DC; Yoon YS; Kim YS; Yoon SA; Ahn SJ; Kim SY; Chang YS; Bang BK; Koh YB
    Clin Transplant; 1996 Dec; 10(6 Pt 1):471-7. PubMed ID: 8996765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry.
    Kaneku HK; Terasaki PI
    Clin Transpl; 2006; ():1-27. PubMed ID: 18368703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion.
    Francis DM; Masendycz PJ; Dumble LJ; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1464-6. PubMed ID: 3274356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.